| scholarly article | Q13442814 |
| P50 | author | Julio Licinio | Q15429111 |
| Ma-Li Wong | Q32848402 | ||
| Pedro Dorado | Q41704704 | ||
| Adrián Llerena | Q56419301 | ||
| P2093 | author name string | E M Peñas-Lledó | |
| I Lares-Asseff | |||
| M G Sosa-Macias | |||
| R E Alanis-Bañuelos | |||
| P2860 | cites work | Cytochrome P4502C9: an enzyme of major importance in human drug metabolism | Q24683497 |
| CYP2C9 allelic variants: ethnic distribution and functional significance | Q28212029 | ||
| Biochemistry and molecular biology of the human CYP2C subfamily | Q28299258 | ||
| Clinical relevance of genetic polymorphisms in the human CYP2C subfamily | Q28362533 | ||
| Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors | Q34429206 | ||
| Clinical relevance of genetic polymorphisms in the human CYP2C9 gene | Q35594567 | ||
| P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. | Q41142872 | ||
| Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype | Q43874208 | ||
| Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes | Q44396463 | ||
| CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers | Q44432237 | ||
| Prevalence of CYP2C9 polymorphisms in the south of Europe. | Q46043535 | ||
| Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards. | Q46975102 | ||
| CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico. | Q54605695 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 108-112 | |
| P577 | publication date | 2010-05-11 | |
| P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
| P1476 | title | CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards | |
| P478 | volume | 11 |
| Q39950111 | Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals |
| Q41631036 | CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy |
| Q57749415 | Distribution of CYP2C Polymorphisms in an Amerindian Population of Brazil |
| Q36365599 | Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations. |
| Q64075045 | Frequency of (, and ) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin |
| Q44760870 | Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study |
| Q51743967 | Genetic variability of CYP2C9*2 and CYP2C9*3 in seven indigenous groups from Mexico. |
| Q92380175 | Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans |
| Q46298744 | Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico. |
| Q47744170 | Interethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain |
| Q56794521 | Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender |
| Q47546933 | P450 Pharmacogenetics in Indigenous North American Populations |
| Q38803190 | Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America. |
| Q37608121 | Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes |
| Q35661209 | Pharmacogenetics of drug-metabolizing enzymes in US Hispanics |
| Q37873934 | Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine. |
| Q35890226 | Pharmacogenomic assessment of Mexican and Peruvian populations |
| Q38643436 | Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes. |
Search more.